<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04913116</url>
  </required_header>
  <id_info>
    <org_study_id>Nat COVID Ag Project</org_study_id>
    <nct_id>NCT04913116</nct_id>
  </id_info>
  <brief_title>Generic Testing of Antigen Tests for COVID-19 in Denmark</brief_title>
  <official_title>Agreement of Antigen Tests on Oral Pharyngeal Swabs or Less Invasive Testing With PCR, for Detecting SARS-CoV-2 in Adults: A Prospective Nationwide Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aalborg University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Herlev and Gentofte Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Slagelse Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sydvestjysk Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sygehus Lillebaelt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Statens Serum Institut</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the analytical and clinical sensitivity and specificity of antigen tests&#xD;
      performed as oropharyngeal swabs, outer nasal swabs, saliva swabs or breath tests including&#xD;
      self-tests for SARS-CoV-2 towards standard RT-PCR testing.&#xD;
&#xD;
      For each test 200 SARS-CoV-2 positive and 200 SARS-CoV-2 negative individuals previously&#xD;
      defined by RT-PCR are tested. When tested an additional RT-PCR test is performed to verify&#xD;
      status.&#xD;
&#xD;
      Analytical sensitivity and specificity is determined on 210 SARS-CoV-2 positive samples with&#xD;
      known Cq and 100 SARS-CoV-2 negative samples.&#xD;
&#xD;
      30 companies with a total of 55 tests participate in this nationwide study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical sensitivity and specificity of each antigen test compared to RT-PCR test result.</measure>
    <time_frame>Up to 3 days after first initial positive COVI-19 RT-PCR test</time_frame>
    <description>Performance is compared for each antigen test in relation to oropharyngeal RT-PCR samples collected simultaneously</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Analytical sensitivity and specificity of each antigen test on retrospectively collected SARS-CoV-2 positive and negative samples.</measure>
    <time_frame>2 months</time_frame>
    <description>SARS-CoV-2 positive samples are stratified into subgroups according to Cq by RT-PCR and frozen samples in universal transport medium is tested on each antigen test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical sensitivity compared to RT-PCR result with the later stratified into low, intermediate and high Cq</measure>
    <time_frame>Up to 3 days after first initial positive COVI-19 RT-PCR test</time_frame>
    <description>Performance of each antigen test in relation to the cycle of quantification Cq by RT-PCR stratified into low (Cq &lt;25), intermediate (Cq 25-35) and High (Cq &gt;35).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Agreement between oropharyngeal swabs and tests from other anatomical test locations by RT-PCR.</measure>
    <time_frame>Up to 3 days after first initial positive COVI-19 RT-PCR test.</time_frame>
    <description>Antigen an RT-PCR tests are performed from multiple anatomical sampling sites on each teste individual.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">4400</enrollment>
  <condition>SARS-CoV2 Infection</condition>
  <condition>COVID-19 Testing</condition>
  <arm_group>
    <arm_group_label>SARS-Cov-2 positives</arm_group_label>
    <description>200 individuals will be tested by each antigen test. Testing is done with up to three swabs at a time from each anatomical test location</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SARS-CoV-2 negatives</arm_group_label>
    <description>200 individuals will be tested by each antigen test. Testing is done with up to three swabs at a time from each anatomical test location</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Comparison of antigen tests with RT-PCR as reference method</intervention_name>
    <description>Antigen tests are performed locally including sampling from multiple anatomical testing sites. A reference oropharyngeal swab is always send for RT-PCR for SARS-CoV-2 at DTU to verify the status of the patient. RT-PCR samples from other anatomical test locations may be included.</description>
    <arm_group_label>SARS-CoV-2 negatives</arm_group_label>
    <arm_group_label>SARS-Cov-2 positives</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      SARS-CoV-2 samples are collected from SARS-CoV-2 positive and negative individuals, analyzed&#xD;
      and discharged&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        approximately 4400 adult out-patients tested for SARS-CoV-2 by RT-PCR within 24 hours prior&#xD;
        to inclusion.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 years or over,&#xD;
&#xD;
          -  Capacity to give informed, written consent&#xD;
&#xD;
          -  Be able to cooperate to the additional testing.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals not fulfilling the inclusion criteria&#xD;
&#xD;
          -  Declining additional oropharyngeal, nasal or saliva swabs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Uffe Schneider, PHD</last_name>
    <phone>+4538623189</phone>
    <email>uffe.vest.schneider@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gorm Lisby, PHD</last_name>
    <phone>+4538622416</phone>
    <email>jan.gorm.lisby@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kasper Mortensen, MD</last_name>
      <phone>+4540256392</phone>
      <email>kaspmort@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Svend Ellermann-Eriksen, MD, PHD, DMSc</last_name>
      <phone>+4578455600</phone>
      <email>sveell@rm.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hvidovre University Hospital</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uffe Schneider, MD, PhD</last_name>
      <phone>+4538623189</phone>
      <email>uffe.vest.schneider@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Gorm Lisby, MD, PhD</last_name>
      <phone>+4538622416</phone>
      <email>jan.gorm.lisby@regionh.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Agergaard, MD</last_name>
      <phone>+4521733440</phone>
      <email>charlotte.agergaard@rsyd.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 12, 2021</study_first_submitted>
  <study_first_submitted_qc>May 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Uffe Schneider</investigator_full_name>
    <investigator_title>Principal Investigator.</investigator_title>
  </responsible_party>
  <keyword>antigen test</keyword>
  <keyword>RT-PCR</keyword>
  <keyword>Prospective samples</keyword>
  <keyword>Retrospective samples</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 19, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT04913116/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

